Pharmacy
The Administration for Strategic Preparedness and Response announced Nov. 3 that it will partner with the Bureau of Industry and Security and the Assistant Secretary of Defense for Health Affairs on an assessment of U.S. pharmaceutical key starting materials in an effort to identify supply chain…
The Department of Labor Oct. 29 finalized a rule designed to improve transparency of fees collected by pharmacy benefit managers.
The median annual net launch price for new prescription drugs increased 35% from 2022 to 2025, to $257,000, according to a report released by the Institute for Clinical and Economic Review and West Health.
A survey released Sept. 10 by the National Comprehensive Cancer Network highlights ongoing shortages of cancer medications.
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for pharmaceutical manufacturers and health systems that depend on a stable medication supply chain.
On June 29, Sen. Bill Cassidy, R-La., unveiled a legislative discussion draft titled the 340B Drug Pricing Integrity and Affordability for Patients Act.
Reps. Scott Peters, D-Calif., and John Joyce, R-Pa., introduced the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, or SECURE 340B Act.
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers.
John Pastor, president of Fairview Pharmacy Services and chief operating officer of Fairview Pharmacy Solutions, shares how M Health Fairview’s expansive pharmacy network, centralized services hub and integrated technology are reshaping medication access in Minnesota and beyond.
As pharmacy closures accelerate nationwide, M Health Fairview is proving what’s possible when a health system steps up.